CN Stock MarketDetailed Quotes

688336 Sunshine Guojian Pharmaceutical

Watchlist
  • 23.18
  • -1.22-5.00%
Market Closed Nov 15 15:00 CST
14.30BMarket Cap39.29P/E (TTM)

Sunshine Guojian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-56.47%525.85M
-43.23%608.34M
-56.26%627.97M
-14.44%933.26M
-20.43%1.21B
-5.20%1.07B
-4.89%1.44B
-32.41%1.09B
-2.24%1.52B
-26.18%1.13B
Transactional financial assets
12.94%792.24M
2.74%770.38M
-8.74%889.34M
-59.37%603.87M
-34.68%701.49M
-44.61%749.87M
8.02%974.56M
97.65%1.49B
21.80%1.07B
45.12%1.35B
Notes receivable and accounts receivable
76.24%241.41M
17.88%185.7M
-4.39%116.16M
-10.79%133.24M
-1.67%136.98M
-2.48%157.54M
-31.81%121.5M
-41.88%149.35M
3.91%139.3M
-33.80%161.55M
-Notes receivable
-5.71%4.53M
2.42%3.74M
78.17%3.51M
-0.73%3.48M
20.97%4.8M
-22.92%3.65M
-42.27%1.97M
-6.61%3.5M
-23.57%3.97M
56.84%4.74M
-Accounts receivable
79.22%236.88M
18.25%181.96M
-5.76%112.65M
-11.03%129.76M
-2.33%132.18M
-1.87%153.89M
-31.60%119.53M
-42.40%145.85M
5.01%135.33M
-34.93%156.81M
Other receivables (including interest and dividends)
201.53%481.3K
51.39%83.5K
-88.02%135.3K
-31.03%201.39K
-60.52%159.62K
-89.97%55.15K
556.98%1.13M
-44.97%291.99K
48.76%404.28K
122.95%550.16K
-Other receivable
----
51.39%83.5K
----
-31.03%201.39K
----
-89.97%55.15K
----
-44.97%291.99K
----
122.95%550.16K
Advance payment
128.04%60.56M
58.05%42.59M
2.53%38M
53.57%36.82M
-8.93%26.55M
20.70%26.95M
36.59%37.06M
-9.83%23.97M
-34.03%29.16M
-21.54%22.33M
Inventories
12.66%203.54M
3.14%188.42M
10.91%218.97M
-14.12%194.96M
-26.81%180.67M
-21.05%182.68M
-13.33%197.42M
8.02%227M
0.45%246.86M
2.74%231.39M
Non-current assets due within one year
--43.17M
--42.82M
----
----
----
----
----
----
----
----
Other current assets
231.94%803.15M
51.17%362.87M
2,661.29%345.08M
3,954.14%347.46M
8,552.12%241.95M
3,000.41%240.04M
1.10%12.5M
-25.52%8.57M
-80.04%2.8M
-44.20%7.74M
Total current assets
6.99%2.67B
-9.36%2.2B
-19.58%2.24B
-24.66%2.25B
-17.10%2.5B
-16.47%2.43B
-2.71%2.78B
4.00%2.99B
4.79%3.01B
-2.29%2.91B
Non Current assets
Other equity investment
45.99%8.71M
69.07%9.55M
52.56%9.99M
43.99%9.07M
-51.19%5.96M
-57.61%5.65M
-50.85%6.55M
-63.53%6.3M
-39.77%12.22M
-34.32%13.33M
Fixed assets
----
17.45%822.72M
----
23.30%874.13M
----
-6.28%700.48M
----
-11.23%708.97M
----
-11.65%747.44M
Constru in process
----
-7.97%717.97M
----
-4.09%687.81M
----
31.37%780.18M
----
25.27%717.11M
----
16.76%593.86M
Intangible assets
-6.64%228.02M
-6.53%232.06M
-6.44%236.11M
22.70%240.16M
22.73%244.23M
22.76%248.29M
31.27%252.36M
-0.41%195.73M
-1.29%199M
-2.81%202.25M
Development expenditure
38.82%144.57M
18.52%105.74M
11.53%73.52M
-61.02%44.44M
2.66%104.14M
-9.92%89.22M
-33.25%65.92M
16.74%114.02M
16.76%101.44M
16.19%99.04M
Goodwill
0.00%639.6K
0.00%639.6K
0.00%639.6K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
Deferred tax assets
-22.28%123.79M
-22.18%131.65M
-21.97%134.5M
-15.97%145.74M
-6.60%159.27M
-0.02%169.17M
7.18%172.38M
11.67%173.43M
20.27%170.51M
33.30%169.21M
Other non current assets
146.78%1.13B
113.27%1.11B
840.02%1.05B
940.27%965M
431.88%457.58M
549.73%518.45M
43.14%111.96M
26.05%92.76M
81.87%86.03M
71.74%79.79M
Total non current assets
23.35%3.25B
22.47%3.2B
45.29%3.15B
44.66%3.06B
29.46%2.63B
29.49%2.61B
7.86%2.17B
4.70%2.11B
3.18%2.03B
3.11%2.02B
Total assets
15.39%5.92B
7.13%5.4B
8.84%5.38B
4.05%5.31B
1.67%5.13B
2.34%5.04B
1.65%4.95B
4.29%5.1B
4.13%5.04B
-0.15%4.92B
Liabilities
Current liabilities
Short term loan
-0.01%50.03M
0.02%50.01M
-0.04%50.02M
-66.67%50.03M
-66.67%50.03M
0.01%50M
--50.04M
--150.1M
--150.1M
--50M
Notes payable and accounts payable
111.00%43.1M
38.13%28.22M
22.07%23.9M
37.79%21.93M
-24.15%20.43M
22.48%20.43M
28.67%19.58M
-2.16%15.91M
41.98%26.93M
-14.17%16.68M
-Accounts payable
111.00%43.1M
38.13%28.22M
22.07%23.9M
37.79%21.93M
-24.15%20.43M
22.48%20.43M
28.67%19.58M
-2.16%15.91M
41.98%26.93M
-14.17%16.68M
Contract liabilities
-73.00%12.24M
1.57%20.84M
194.41%39.51M
-14.22%16.77M
64.03%45.34M
-31.29%20.52M
-62.72%13.42M
501.32%19.55M
255.11%27.64M
151.40%29.86M
Advance receipts
--439.57M
----
----
----
----
----
----
----
----
----
Salaries payable
32.90%44.91M
23.13%45.61M
1.79%25.54M
-9.24%40.97M
-15.21%33.79M
0.58%37.04M
-14.80%25.09M
0.87%45.14M
3.95%39.85M
-14.72%36.83M
Taxs payable
-0.49%5.22M
25.36%6.45M
2.38%5.9M
-12.64%6.98M
21.62%5.25M
64.81%5.15M
-8.17%5.76M
-4.70%7.99M
2.78%4.32M
-53.93%3.12M
Other payable (including interest and dividends)
70.11%165.52M
84.64%168.46M
84.50%158.08M
25.71%171.46M
-17.28%97.31M
-25.73%91.24M
-24.89%85.68M
-4.48%136.4M
19.30%117.64M
-18.93%122.85M
-Other payable
----
84.64%168.46M
----
25.71%171.46M
----
-25.73%91.24M
----
-4.48%136.4M
----
-18.93%122.85M
Total current liabilities
201.65%760.6M
42.44%319.6M
51.80%302.95M
-17.85%308.14M
-31.20%252.15M
-13.48%224.38M
-0.72%199.57M
74.09%375.09M
118.28%366.48M
11.39%259.34M
Current liabilities
Long term deferred income
-3.52%111.67M
-9.33%108.28M
-5.44%113.31M
-4.41%118.33M
-4.43%115.75M
-4.61%119.43M
-7.58%119.83M
-7.81%123.79M
-12.81%121.11M
-12.04%125.2M
Total non current liabilities
-3.52%111.67M
-9.33%108.28M
-5.44%113.31M
-4.41%118.33M
-4.43%115.75M
-4.61%119.43M
-7.58%119.83M
-7.81%123.79M
-13.21%121.11M
-12.44%125.2M
Total liabilities
137.10%872.27M
24.45%427.88M
30.33%416.25M
-14.51%426.47M
-24.55%367.9M
-10.59%343.81M
-3.41%319.39M
42.65%498.88M
58.60%487.59M
2.33%384.54M
Shareholders equity
Paid-in capital
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.09%616.79M
0.09%616.79M
0.09%616.79M
0.09%616.79M
Capital reserve funds
-0.23%2.31B
-0.31%2.3B
-0.31%2.3B
-0.27%2.3B
0.01%2.31B
0.05%2.31B
0.19%2.31B
0.34%2.31B
0.52%2.31B
0.63%2.31B
Surplus reserve funds
11.48%307.33M
11.48%307.33M
11.48%307.33M
11.48%307.33M
0.00%275.68M
0.00%275.68M
0.00%275.68M
0.00%275.68M
0.00%275.68M
0.00%275.68M
Retained profit
17.79%1.86B
17.68%1.78B
22.13%1.77B
18.58%1.68B
15.51%1.58B
11.13%1.51B
6.04%1.45B
3.61%1.42B
1.00%1.37B
-0.84%1.36B
Other composite income
-160.47%-15.95M
-103.36%-11.25M
44.40%-7.78M
18.34%-8.71M
-76.19%-6.12M
56.94%-5.53M
36.54%-14M
38.43%-10.67M
57.81%-3.47M
-52.28%-12.85M
Shareholders equity without minority interests
6.23%5.07B
6.07%4.99B
7.57%4.99B
6.30%4.9B
4.59%4.78B
3.51%4.71B
2.10%4.64B
1.42%4.61B
0.68%4.57B
-0.02%4.55B
Minority interests
-81.68%-27.87M
-90.59%-22.72M
-115.48%-19.94M
-177.96%-17.58M
-59.22%-15.34M
-42.36%-11.92M
-71.05%-9.25M
-156.93%-6.32M
-1,037.38%-9.63M
-223.07%-8.37M
Total shareholder equity
5.99%5.05B
5.86%4.97B
7.36%4.97B
6.07%4.88B
4.48%4.76B
3.44%4.69B
2.02%4.63B
1.33%4.6B
0.44%4.56B
-0.36%4.54B
Total liabilityies and equity
15.39%5.92B
7.13%5.4B
8.84%5.38B
4.05%5.31B
1.67%5.13B
2.34%5.04B
1.65%4.95B
4.29%5.1B
4.13%5.04B
-0.15%4.92B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
--
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -56.47%525.85M-43.23%608.34M-56.26%627.97M-14.44%933.26M-20.43%1.21B-5.20%1.07B-4.89%1.44B-32.41%1.09B-2.24%1.52B-26.18%1.13B
Transactional financial assets 12.94%792.24M2.74%770.38M-8.74%889.34M-59.37%603.87M-34.68%701.49M-44.61%749.87M8.02%974.56M97.65%1.49B21.80%1.07B45.12%1.35B
Notes receivable and accounts receivable 76.24%241.41M17.88%185.7M-4.39%116.16M-10.79%133.24M-1.67%136.98M-2.48%157.54M-31.81%121.5M-41.88%149.35M3.91%139.3M-33.80%161.55M
-Notes receivable -5.71%4.53M2.42%3.74M78.17%3.51M-0.73%3.48M20.97%4.8M-22.92%3.65M-42.27%1.97M-6.61%3.5M-23.57%3.97M56.84%4.74M
-Accounts receivable 79.22%236.88M18.25%181.96M-5.76%112.65M-11.03%129.76M-2.33%132.18M-1.87%153.89M-31.60%119.53M-42.40%145.85M5.01%135.33M-34.93%156.81M
Other receivables (including interest and dividends) 201.53%481.3K51.39%83.5K-88.02%135.3K-31.03%201.39K-60.52%159.62K-89.97%55.15K556.98%1.13M-44.97%291.99K48.76%404.28K122.95%550.16K
-Other receivable ----51.39%83.5K-----31.03%201.39K-----89.97%55.15K-----44.97%291.99K----122.95%550.16K
Advance payment 128.04%60.56M58.05%42.59M2.53%38M53.57%36.82M-8.93%26.55M20.70%26.95M36.59%37.06M-9.83%23.97M-34.03%29.16M-21.54%22.33M
Inventories 12.66%203.54M3.14%188.42M10.91%218.97M-14.12%194.96M-26.81%180.67M-21.05%182.68M-13.33%197.42M8.02%227M0.45%246.86M2.74%231.39M
Non-current assets due within one year --43.17M--42.82M--------------------------------
Other current assets 231.94%803.15M51.17%362.87M2,661.29%345.08M3,954.14%347.46M8,552.12%241.95M3,000.41%240.04M1.10%12.5M-25.52%8.57M-80.04%2.8M-44.20%7.74M
Total current assets 6.99%2.67B-9.36%2.2B-19.58%2.24B-24.66%2.25B-17.10%2.5B-16.47%2.43B-2.71%2.78B4.00%2.99B4.79%3.01B-2.29%2.91B
Non Current assets
Other equity investment 45.99%8.71M69.07%9.55M52.56%9.99M43.99%9.07M-51.19%5.96M-57.61%5.65M-50.85%6.55M-63.53%6.3M-39.77%12.22M-34.32%13.33M
Fixed assets ----17.45%822.72M----23.30%874.13M-----6.28%700.48M-----11.23%708.97M-----11.65%747.44M
Constru in process -----7.97%717.97M-----4.09%687.81M----31.37%780.18M----25.27%717.11M----16.76%593.86M
Intangible assets -6.64%228.02M-6.53%232.06M-6.44%236.11M22.70%240.16M22.73%244.23M22.76%248.29M31.27%252.36M-0.41%195.73M-1.29%199M-2.81%202.25M
Development expenditure 38.82%144.57M18.52%105.74M11.53%73.52M-61.02%44.44M2.66%104.14M-9.92%89.22M-33.25%65.92M16.74%114.02M16.76%101.44M16.19%99.04M
Goodwill 0.00%639.6K0.00%639.6K0.00%639.6K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K
Deferred tax assets -22.28%123.79M-22.18%131.65M-21.97%134.5M-15.97%145.74M-6.60%159.27M-0.02%169.17M7.18%172.38M11.67%173.43M20.27%170.51M33.30%169.21M
Other non current assets 146.78%1.13B113.27%1.11B840.02%1.05B940.27%965M431.88%457.58M549.73%518.45M43.14%111.96M26.05%92.76M81.87%86.03M71.74%79.79M
Total non current assets 23.35%3.25B22.47%3.2B45.29%3.15B44.66%3.06B29.46%2.63B29.49%2.61B7.86%2.17B4.70%2.11B3.18%2.03B3.11%2.02B
Total assets 15.39%5.92B7.13%5.4B8.84%5.38B4.05%5.31B1.67%5.13B2.34%5.04B1.65%4.95B4.29%5.1B4.13%5.04B-0.15%4.92B
Liabilities
Current liabilities
Short term loan -0.01%50.03M0.02%50.01M-0.04%50.02M-66.67%50.03M-66.67%50.03M0.01%50M--50.04M--150.1M--150.1M--50M
Notes payable and accounts payable 111.00%43.1M38.13%28.22M22.07%23.9M37.79%21.93M-24.15%20.43M22.48%20.43M28.67%19.58M-2.16%15.91M41.98%26.93M-14.17%16.68M
-Accounts payable 111.00%43.1M38.13%28.22M22.07%23.9M37.79%21.93M-24.15%20.43M22.48%20.43M28.67%19.58M-2.16%15.91M41.98%26.93M-14.17%16.68M
Contract liabilities -73.00%12.24M1.57%20.84M194.41%39.51M-14.22%16.77M64.03%45.34M-31.29%20.52M-62.72%13.42M501.32%19.55M255.11%27.64M151.40%29.86M
Advance receipts --439.57M------------------------------------
Salaries payable 32.90%44.91M23.13%45.61M1.79%25.54M-9.24%40.97M-15.21%33.79M0.58%37.04M-14.80%25.09M0.87%45.14M3.95%39.85M-14.72%36.83M
Taxs payable -0.49%5.22M25.36%6.45M2.38%5.9M-12.64%6.98M21.62%5.25M64.81%5.15M-8.17%5.76M-4.70%7.99M2.78%4.32M-53.93%3.12M
Other payable (including interest and dividends) 70.11%165.52M84.64%168.46M84.50%158.08M25.71%171.46M-17.28%97.31M-25.73%91.24M-24.89%85.68M-4.48%136.4M19.30%117.64M-18.93%122.85M
-Other payable ----84.64%168.46M----25.71%171.46M-----25.73%91.24M-----4.48%136.4M-----18.93%122.85M
Total current liabilities 201.65%760.6M42.44%319.6M51.80%302.95M-17.85%308.14M-31.20%252.15M-13.48%224.38M-0.72%199.57M74.09%375.09M118.28%366.48M11.39%259.34M
Current liabilities
Long term deferred income -3.52%111.67M-9.33%108.28M-5.44%113.31M-4.41%118.33M-4.43%115.75M-4.61%119.43M-7.58%119.83M-7.81%123.79M-12.81%121.11M-12.04%125.2M
Total non current liabilities -3.52%111.67M-9.33%108.28M-5.44%113.31M-4.41%118.33M-4.43%115.75M-4.61%119.43M-7.58%119.83M-7.81%123.79M-13.21%121.11M-12.44%125.2M
Total liabilities 137.10%872.27M24.45%427.88M30.33%416.25M-14.51%426.47M-24.55%367.9M-10.59%343.81M-3.41%319.39M42.65%498.88M58.60%487.59M2.33%384.54M
Shareholders equity
Paid-in capital 0.00%616.79M0.00%616.79M0.00%616.79M0.00%616.79M0.00%616.79M0.00%616.79M0.09%616.79M0.09%616.79M0.09%616.79M0.09%616.79M
Capital reserve funds -0.23%2.31B-0.31%2.3B-0.31%2.3B-0.27%2.3B0.01%2.31B0.05%2.31B0.19%2.31B0.34%2.31B0.52%2.31B0.63%2.31B
Surplus reserve funds 11.48%307.33M11.48%307.33M11.48%307.33M11.48%307.33M0.00%275.68M0.00%275.68M0.00%275.68M0.00%275.68M0.00%275.68M0.00%275.68M
Retained profit 17.79%1.86B17.68%1.78B22.13%1.77B18.58%1.68B15.51%1.58B11.13%1.51B6.04%1.45B3.61%1.42B1.00%1.37B-0.84%1.36B
Other composite income -160.47%-15.95M-103.36%-11.25M44.40%-7.78M18.34%-8.71M-76.19%-6.12M56.94%-5.53M36.54%-14M38.43%-10.67M57.81%-3.47M-52.28%-12.85M
Shareholders equity without minority interests 6.23%5.07B6.07%4.99B7.57%4.99B6.30%4.9B4.59%4.78B3.51%4.71B2.10%4.64B1.42%4.61B0.68%4.57B-0.02%4.55B
Minority interests -81.68%-27.87M-90.59%-22.72M-115.48%-19.94M-177.96%-17.58M-59.22%-15.34M-42.36%-11.92M-71.05%-9.25M-156.93%-6.32M-1,037.38%-9.63M-223.07%-8.37M
Total shareholder equity 5.99%5.05B5.86%4.97B7.36%4.97B6.07%4.88B4.48%4.76B3.44%4.69B2.02%4.63B1.33%4.6B0.44%4.56B-0.36%4.54B
Total liabilityies and equity 15.39%5.92B7.13%5.4B8.84%5.38B4.05%5.31B1.67%5.13B2.34%5.04B1.65%4.95B4.29%5.1B4.13%5.04B-0.15%4.92B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --------------Unqualified opinion----
Auditor --------------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data